GLIEMPAFLOZIN LINA 10MG/ 5MG

Empagliflozin and linagliptin tablets are prescription combination medicines used to help control blood sugar in adults with type 2 diabetes mellitus. This combination brings together two different classes of diabetes medicines: empagliflozin, an SGLT2 inhibitor, and linagliptin, a DPP-4 inhibitor. By working through complementary mechanisms, the combination can help improve blood-glucose control when diet, exercise, or existing diabetes treatment alone is not sufficient.

If you are searching for empagliflozin and linagliptin tablets, you may be comparing brands, strengths, prices, uses, benefits, or side effects before purchasing. Current Indian online pharmacy listings show combinations such as empagliflozin 10 mg + linagliptin 5 mg and empagliflozin 25 mg + linagliptin 5 mg. These products are listed as prescription medicines, and prices can vary according to brand, pack size, pharmacy discounts, and availability. 

What Are Empagliflozin and Linagliptin Tablets?

Empagliflozin and linagliptin tablets contain two active ingredients that lower blood glucose in different ways.

Empagliflozin belongs to the sodium-glucose cotransporter-2 (SGLT2) inhibitor class. It reduces the reabsorption of glucose by the kidneys, allowing more glucose to leave the body through urine.

Linagliptin belongs to the DPP-4 inhibitor class. It increases the activity of incretin hormones, helping the body release insulin in a glucose-dependent manner and reducing glucagon activity when blood glucose is elevated.

The combination therefore provides two complementary approaches to blood-sugar management. Current prescribing information includes evidence that empagliflozin 10 mg or 25 mg combined with linagliptin 5 mg can improve HbA1c compared with appropriate comparator treatment. 

Empagliflozin and Linagliptin Tablets Uses

The primary use of this combination is to improve blood glucose control in adults with type 2 diabetes.

A doctor may prescribe the combination when additional glucose lowering is needed despite diet, physical activity, and/or existing diabetes treatment.

It is important to understand that these tablets are not intended to treat type 1 diabetes and should not be used as a replacement for insulin in people who require insulin therapy.

Treatment should be individualized because diabetes can affect the kidneys, heart, blood vessels, eyes, and nerves. Your healthcare professional can determine whether this combination is appropriate based on your glucose levels, kidney function, other medicines, and overall health.

How Empagliflozin and Linagliptin Work

The two medicines target different processes involved in blood glucose regulation.

Empagliflozin

Empagliflozin acts on the kidneys by blocking SGLT2, a protein responsible for reabsorbing glucose from urine back into the bloodstream. Blocking this transporter increases urinary glucose excretion and helps lower blood glucose.

Because it increases glucose and fluid loss through urine, patients may urinate more frequently and can become dehydrated if they do not maintain appropriate fluid intake.

Linagliptin

Linagliptin inhibits DPP-4, an enzyme that breaks down incretin hormones. Increased incretin activity helps the pancreas release insulin in response to elevated glucose and reduces glucagon secretion.

The two mechanisms complement one another, providing a broader approach to glucose control.

Key Benefits of Empagliflozin and Linagliptin Tablets

When prescribed for the appropriate patient, the combination can offer several potential benefits.

1. Helps improve blood-sugar control

The combination targets blood glucose through two different mechanisms and can help lower elevated glucose levels when used as part of an appropriate diabetes management plan.

2. Two medicines in one tablet

A combination tablet can simplify treatment for patients who have been prescribed both active ingredients separately. This may reduce the number of individual tablets in a daily medication routine.

3. Convenient dosing

Many marketed combinations are designed for once-daily administration, although the appropriate dose depends on the prescribed product and the patient's medical circumstances. Current Indian product listings for both 10/5 mg and 25/5 mg combinations describe once-daily use according to a doctor's instructions. 

4. Complementary mechanisms

Empagliflozin promotes urinary glucose elimination, while linagliptin enhances incretin activity. Combining these mechanisms can provide additional glucose lowering compared with relying on only one mechanism.

5. May offer benefits beyond glucose lowering

Empagliflozin has established cardiovascular and kidney-related benefits in specific populations and indications. However, these benefits should not automatically be attributed to every empagliflozin/linagliptin product or every patient. Your doctor determines whether the combination is appropriate for your individual cardiovascular and kidney-risk profile.

Empagliflozin and Linagliptin Side Effects

Like all medicines, empagliflozin and linagliptin tablets can cause side effects.

Potential side effects associated with this combination may include:

• Increased urination
• Genital fungal infections
• Urinary tract infections
• Dehydration or low blood pressure
• Nasopharyngitis or cold-like symptoms
• Upper respiratory tract infections
• Headache
• Gastrointestinal discomfort
• Hypoglycemia, particularly when combined with insulin or certain other glucose-lowering medicines

Current Indian listings for marketed empagliflozin/linagliptin combinations identify urinary tract infections, nasopharyngitis, and upper respiratory tract infections among common adverse effects. 

Important serious side effects

Seek urgent medical attention if you develop symptoms that could indicate a serious reaction, severe dehydration, or other significant complications.

SGLT2 inhibitors such as empagliflozin can rarely be associated with diabetic ketoacidosis, including cases where blood glucose is not extremely high. Warning symptoms can include nausea, vomiting, abdominal pain, unusual tiredness, or difficulty breathing.

Genital infections and urinary infections can also occur because glucose is eliminated through urine.

Do not ignore severe or unusual symptoms simply because the medicine is being used for diabetes.

How to Take Empagliflozin and Linagliptin Tablets

Take the medicine exactly as prescribed.

Depending on the specific product, empagliflozin and linagliptin tablets may generally be taken with or without food. Current Indian product listings for both 10/5 mg and 25/5 mg combinations provide this administration guidance. 

Swallow the tablet whole unless your product's prescribing information says otherwise.

Do not increase the dose because your blood sugar remains high, and do not stop treatment without consulting your doctor.

Adequate hydration is particularly important with empagliflozin because the medicine increases urinary glucose and fluid loss.

Who Should Use Caution?

Tell your doctor before taking empagliflozin and linagliptin tablets if you have:

• Kidney disease or reduced kidney function
• Liver disease
• A history of pancreatitis
• Recurrent urinary or genital infections
• Low blood pressure or dehydration
• Heart disease
• A history of diabetic ketoacidosis
• Pregnancy or plans to become pregnant
• Breastfeeding
• An upcoming major surgery or prolonged period of fasting

Kidney function is particularly important when evaluating medicines containing empagliflozin. Your doctor may check kidney function before and during treatment.

The exact contraindications and precautions can differ between products and jurisdictions, so the prescribing information supplied with your specific medicine should be followed.

Can You Buy Empagliflozin and Linagliptin Tablets Online?

If you want to buy empagliflozin and linagliptin tablets online, choose a legitimate pharmacy and ensure that the medicine matches your prescription.

Current Indian listings show multiple brands containing these ingredients. For example, listings updated in August–September 2026 show 25 mg empagliflozin + 5 mg linagliptin products with prices varying from roughly ₹120 to above ₹200 for some 10-tablet packs, depending on the brand and current discount. A 10 mg + 5 mg product is also currently listed around ₹149 MRP for a 10-tablet strip before applicable offers. Prices and availability can change quickly. 

Before purchasing, verify:

• Active ingredients: empagliflozin + linagliptin
• Strength: 10/5 mg or 25/5 mg, exactly as prescribed
• Manufacturer and brand
• Pack size
• Batch and expiry information
• Prescription requirement
• Pharmacy authenticity
• Final price and delivery charges

Do not select a product only because it has the lowest online price. The correct strength and formulation are more important.

10/5 mg vs 25/5 mg: Which Is Better?

Both strengths contain linagliptin 5 mg, but they contain different amounts of empagliflozin.

• 10/5 mg: empagliflozin 10 mg + linagliptin 5 mg
• 25/5 mg: empagliflozin 25 mg + linagliptin 5 mg

Neither strength is universally “better.” The appropriate strength depends on your treatment plan, blood-glucose control, kidney function, previous medicines, tolerability, and your doctor's assessment.

Never switch from 10/5 mg to 25/5 mg simply because you believe a higher dose will lower glucose faster.

Buyer Guide: What to Check Before Ordering

People searching for empagliflozin and linagliptin tablet prices often compare several brands. A useful comparison should go beyond the advertised price.

Check the composition first, then compare the strength, manufacturer, tablet count, prescription requirements, expiry date, and final payable amount.

Indian online listings demonstrate that products with the same active ingredients can have significantly different prices. For example, current listings include brands from manufacturers such as Zydus, Lupin, Cipla, Intas, Mankind, and others. 

This does not mean the cheapest product is automatically the best choice. Ask your pharmacist or doctor whether a specific brand is an appropriate substitute for the one prescribed.

E-E-A-T Safety & Medical Information

For a diabetes medicine, trustworthy content should distinguish between general product information and individualized medical advice.

Empagliflozin and linagliptin tablets can help manage type 2 diabetes, but they are not a cure for diabetes. Long-term diabetes care may also involve nutrition, physical activity, blood-glucose monitoring, weight management, blood-pressure control, cholesterol management, and regular medical checkups.

Do not use online product information to diagnose diabetes or decide your own dosage. A qualified healthcare professional should determine whether the combination and strength are appropriate.

Conclusion

Empagliflozin and linagliptin tablets combine two complementary diabetes medicines to help improve blood glucose control in adults with type 2 diabetes. Empagliflozin works through the kidneys to increase glucose elimination in urine, while linagliptin enhances incretin activity to support glucose-dependent insulin release.

The main potential advantages include improved glucose control, complementary mechanisms, and the convenience of combining two active ingredients in one tablet. However, side effects such as urinary or genital infections, increased urination, dehydration, and respiratory symptoms can occur, while rare but serious complications require prompt medical attention.

If you plan to buy empagliflozin and linagliptin tablets online, confirm the exact prescribed strength—particularly whether it is 10/5 mg or 25/5 mg—and purchase from a legitimate pharmacy. Current Indian market listings show substantial price differences between brands, so buyers should compare composition, strength, pack size, manufacturer, prescription requirements, and final price rather than choosing solely on cost. 

Always take this medicine according to your doctor's instructions and do not change the dose or switch strengths without professional guidance.

Frequently Asked Questions 

1. What are empagliflozin and linagliptin tablets used for?

Empagliflozin and linagliptin tablets are used with diet and exercise to improve blood-sugar control in adults with type 2 diabetes. The two medicines lower glucose through different mechanisms. 

2. What are the benefits of empagliflozin and linagliptin tablets?

The combination can provide additional blood-glucose control through two complementary mechanisms. It also combines two diabetes medicines into one tablet, which can simplify a prescribed treatment routine.

3. What are the common side effects of empagliflozin and linagliptin tablets?

Commonly reported effects can include increased urination, urinary tract infections, genital infections, nasopharyngitis, upper respiratory infections, and headache. The risk of hypoglycemia may increase when the combination is used with insulin or certain other diabetes medicines. 

4. What is the difference between empagliflozin 10 mg + linagliptin 5 mg and 25 mg + linagliptin 5 mg?

Both combinations contain linagliptin 5 mg, but the amount of empagliflozin differs. The 10/5 mg tablet contains 10 mg of empagliflozin, while the 25/5 mg tablet contains 25 mg. Your doctor should decide which strength is appropriate.

5. Can I take empagliflozin and linagliptin tablets with food?

Many marketed combinations can be taken with or without food. However, follow the instructions for your specific product and your doctor's prescription. 

6. Can I buy empagliflozin and linagliptin tablets online?

Yes, these combination products are currently listed by Indian online pharmacies, but they are prescription medicines. Use a legitimate pharmacy and provide a valid prescription when required. 

7. Is the empagliflozin and linagliptin combination safe for kidney patients?

It depends on the patient's kidney function and overall medical condition. Empagliflozin-containing medicines have specific kidney-function considerations, so people with kidney disease should consult their doctor before starting or changing treatment.

8. Can empagliflozin and linagliptin tablets cause low blood sugar?

The risk may be relatively low when these medicines are used alone, but hypoglycemia can become more likely when they are combined with insulin or certain other glucose-lowering medicines. Your treatment plan should therefore be monitored by a healthcare professional.

9. Can I stop taking empagliflozin and linagliptin when my blood sugar improves?

No. Do not stop or change your diabetes medicine without medical advice. Improved glucose readings may indicate that your treatment is working rather than that the medicine is no longer needed.

10. What should I check before buying these diabetes tablets?

Check the prescribed empagliflozin and linagliptin strength, active ingredients, manufacturer, pack size, expiry date, prescription requirement, pharmacy authenticity, and final price. Do not substitute 10/5 mg and 25/5 mg products without your doctor's approval.